Betz et al., 1978 - Google Patents
Polarity of the blood-brain barrier: neutral amino acid transport into isolated brain capillariesBetz et al., 1978
- Document ID
- 7189356032410542531
- Author
- Betz A
- Goldstein G
- Publication year
- Publication venue
- Science
External Links
Snippet
Capillary endothelial cells isolated from rat brain exhibit Na+-dependent uptake of the neutral amino acid analog α-(methylamino) isobutyric acid. Since studies in vivo demonstrate that this transport system is not present on the blood side of brain capillaries we …
- 150000001413 amino acids 0 title abstract description 24
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharide having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Betz et al. | Polarity of the blood-brain barrier: neutral amino acid transport into isolated brain capillaries | |
| Hirsch et al. | Lecithin consumption increases acetylcholine concentrations in rat brain and adrenal gland | |
| US5254572A (en) | Method and composition for supplementing vitamin B6 where the PN-PLP pathway is disturbed | |
| Levander | Lead toxicity and nutritional deficiencies. | |
| CA2071971C (en) | The use of arginine as an immunostimulator | |
| US20060074051A1 (en) | Therapeutic stem cell growth factor composition, anti-inflammatory composition, and uses thereof | |
| JP2002518440A (en) | Compositions and uses comprising β-hydroxy-β-methylbutyric acid and at least one amino acid | |
| US20060241086A1 (en) | Calcium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate as an allosteric effector of hemoglobin | |
| JP2859319B2 (en) | Medication for disorders related to transplantation containing inositol triphosphate | |
| CN109452651B (en) | Endurance composition | |
| Orrego-Matte et al. | Ethanol ingestion and incorporation of 32P into phospholipids of pancreas in the rat | |
| Tenner Jr et al. | Hypoglycemic effects of taurine in the alloxan-treated rabbit, a model for type 1 diabetes | |
| EP0166436A2 (en) | Use of dolichol or its ester in medicines | |
| KR100304312B1 (en) | Zinc Supplemented Prostate Extract | |
| Skoutakis et al. | Folie acid dosage for chronic hemodialysis patients | |
| US20110318333A1 (en) | Novel non-toxic composition and method of using such for treating a degenerative or an immune system-related disease | |
| US5001117A (en) | Use of lecithin to restore olfaction and taste | |
| US20060106000A1 (en) | Use of inositol-tripyrophosphate in treating tumors and diseases | |
| JPH0155249B2 (en) | ||
| Kenny et al. | Clinical zinc deficiency during adequate enteral nutrition. | |
| Kilic et al. | The effects of fusidic acid on the inflammatory response in rats | |
| Worth | Azathioprine effect on normal canine liver and kidney function | |
| WO2003086078A1 (en) | Method of reducing calcified arterial plaque buildup and cellular malfunction and for balancing ionic calcium | |
| Biolo et al. | Relationship between whole-body protein turnover and serum creatinine in chronically uremic patients | |
| US6254871B1 (en) | Therapeutic uses of specially processed garlic for sickle cell disease |